The therapy, a fully human monoclonal antibody, targets a newly identified immune checkpoint protein that could enhance ...

While PD-1/PD-L1 blockade has demonstrated remarkable clinical successes, recent studies suggest that its novel target has a ...

Iontra will show an extended cycle life improvement using a Veken Pouch Cell (3.2Ah, LCO/GR Chemistry), a Pluto-1S50 module, ...

The therapy, a fully human monoclonal antibody, targets a newly identified immune checkpoint protein that could enhance ...

AbTree Biologics AG has signed an exclusive co-development and commercialization partnership with Shilpa Biologicals Pvt Ltd.

Shilpa Medicare soared 10.46% to Rs 696.15 after the company's wholly owned subsidiary, Shilpa Biologicals, inked a strategic partnership with Switzerland-based mAbTree Biologics AG to co-develop and ...

Approval based on ADRIATIC Phase III trial results which showed a 27% reduction in the risk of death versus placebo ...

BioNTech is expanding its oncology pipeline with FixVac, iNeST, and BNT327 for individualized cancer treatments. Read why I ...

The table is a review of notable updates that occurred in February 2025 for investigational products in development.

Nikolas Sedillio served 11 months in the McLennan County jail, charged for a crime he never committed. In late January, ...

Salma Mohamed, 17, remains undeterred by Trump’s attacks on science. The Lo-Ellen Park student helped organize the March 7 ...